From Bench to Bedside: Targeted Therapy, Denosumab, and 21st Century Orthopaedics: Targets Abound, But Where Are The Therapies? [electronic resource]
Producer: 20160711Description: 892-4 p. digitalISSN:- 1528-1132
- Animals
- Antineoplastic Agents -- adverse effects
- Bone Density Conservation Agents -- adverse effects
- Cost-Benefit Analysis
- Denosumab -- adverse effects
- Diffusion of Innovation
- Drug Costs
- Drug Discovery -- economics
- Humans
- Molecular Targeted Therapy -- economics
- Research Support as Topic
- Translational Research, Biomedical -- economics
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.